Clinical Trials in Cedex, France
Locations / Cedex, France
Delta Trials records 17 clinical trials conducted in Cedex, France, making it a notable site of clinical research activity. These trials across 33 distinct therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 5 trials in this location were terminated, reflecting shifts in research priorities or feasibility. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity in Cedex has changed over time.
17
Total Trials
33
Conditions
5
Terminated since 2020
Browse by condition (33 total)
- Non-small cell lung cancer 2 trialsAll Non-small cell lung cancer trials
- Transthyretin gene mutations 1 trialAll Transthyretin gene mutations trials
- All Ann arbor stage iiia hodgkin lymphoma trials
- All Ann arbor stage iva hodgkin lymphoma trials
- Transthyretin amyloidosis 1 trialAll Transthyretin amyloidosis trials
- T-cell non-hodgkin's lymphoma 1 trialAll T-cell non-hodgkin's lymphoma trials
- HIV infections 1 trialAll HIV infections trials
- All Ann arbor stage ivb hodgkin lymphoma trials
- All Ann arbor stage iiib hodgkin lymphoma trials
- Lung cancer 1 trialAll Lung cancer trials
- HIV infection 1 trialAll HIV infection trials
- Hyperphosphatemia 1 trialAll Hyperphosphatemia trials
- All Ann arbor stage ii hodgkin lymphoma trials
- Prostate cancer 1 trialAll Prostate cancer trials
- Acute coronary syndrome 1 trialAll Acute coronary syndrome trials
- All Ann arbor stage iib hodgkin lymphoma trials
- Hemoglobinuria, paroxysmal 1 trialAll Hemoglobinuria, paroxysmal trials
- All Ann arbor stage iv hodgkin lymphoma trials
- All Breast cancer with low to intermediate her2 expression trials
- All Myeloid leukemia, chronic, chronic-phase trials